Naproxen Sodium
- Product NDC
- 68788-6934
- 11-digit product format
- 687886934
- Labeler code
- 68788
- Product ID
- 68788-6934_569e3e31-2f72-4d83-9efe-6f7229072e0d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA078314
- Marketing category
- ANDA
- Marketing start
- 2017-03-27
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-6934-1 | 68788693401 | 100 TABLET in 1 BOTTLE (68788-6934-1) | 100 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-2 | 68788693402 | 20 TABLET in 1 BOTTLE (68788-6934-2) | 20 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-3 | 68788693403 | 30 TABLET in 1 BOTTLE (68788-6934-3) | 30 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-4 | 68788693404 | 14 TABLET in 1 BOTTLE (68788-6934-4) | 14 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-6 | 68788693406 | 60 TABLET in 1 BOTTLE (68788-6934-6) | 60 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-8 | 68788693408 | 120 TABLET in 1 BOTTLE (68788-6934-8) | 120 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |
| 68788-6934-9 | 68788693409 | 90 TABLET in 1 BOTTLE (68788-6934-9) | 90 tablet | 2017-03-27 | 0000-00-00 | No | No | Current |